Bunge Global director awarded 13 restricted units

Bunge Global SA director Christopher Mahoney reported acquiring 13 restricted stock units of common stock on March 3, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Bunge Global SA director Christopher Mahoney reported acquiring 13 restricted stock units of common stock on March 3, 2026. These units were credited under a dividend feature in the company’s long-term incentive plans and increased his directly held common stock-related position to 7,210 shares-equivalent.

Insider Trade Summary

Grant/Award: 13 shares

Grant/Award 1 txn

Insider Mahoney Christopher

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13	$116.83	$2K

Holdings After Transaction: Common Stock — 7,210 shares (Direct)

Footnotes (1)

F1. Represents restricted stock units acquired on March 3, 2026 pursuant to a dividend feature under the registrant's long-term incentive plans.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Christopher Mahoney report at Bunge Global (BG)?

Christopher Mahoney reported acquiring 13 restricted stock units of Bunge Global common stock. The units were granted on March 3, 2026 through a dividend feature in the company’s long-term incentive plans, adding to his existing directly held common stock-related position.

Was Christopher Mahoney’s Bunge Global Form 4 transaction a market purchase or a grant?

The transaction was a grant, not an open-market purchase. Mahoney acquired 13 restricted stock units credited under a dividend feature of Bunge Global’s long-term incentive plans, rather than buying common shares directly in the market at his own discretion.

How many Bunge Global shares does Christopher Mahoney hold after this Form 4 transaction?

After this transaction, Christopher Mahoney reported beneficial ownership of 7,210 shares of Bunge Global common stock. This total includes the 13 newly acquired restricted stock units credited via the long-term incentive plan’s dividend feature on March 3, 2026.

At what reference price were Christopher Mahoney’s restricted stock units recorded?

The 13 restricted stock units were recorded at a reference price of $116.83 per share of Bunge Global common stock. This price is shown purely as an accounting measure for the award, rather than reflecting an actual cash transaction in the open market.

What is the nature of ownership for Christopher Mahoney’s Bunge Global shares in this filing?

The filing classifies Christopher Mahoney’s ownership as direct. The 7,210 shares, including the 13 restricted stock units from the March 3, 2026 dividend feature grant, are reported as directly owned, with no indication of indirect ownership through entities or related persons.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/05/2026 - 05:02 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mahoney Christopher

(Last)

(First)

(Middle)

C/O BUNGE GLOBAL SA

1391 TIMBERLAKE MANOR PARKWAY

(Street)

CHESTERFIELD

63017

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Bunge Global SA [ BG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/03/2026		A		13⁽¹⁾	A	$116.83	7,210	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted stock units acquired on March 3, 2026 pursuant to a dividend feature under the registrant's long-term incentive plans.

Remarks:

	/s/ Drew Yaeger, Attorney-in-Fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR